Landos Biopharma, Inc.(LABP)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LABP Landos Biopharma, Inc.

盘后交易 07-23 17:22:29 EDT

22.93

+0.00

0.00%

最高22.93	最低22.93	成交量0.00
今开22.93	昨收22.93	日振幅0.00%
总市值7,168万	流通市值3,047万	总股本312.58万
成交额0.00	换手率0.00%	流通股本132.89万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LABP","market":"US","secType":"STK","nameCN":"Landos Biopharma, Inc.","latestPrice":22.93,"timestamp":1721764800000,"preClose":22.93,"halted":0,"volume":0,"delay":0,"floatShares":1328861,"shares":3125841,"eps":-3.995355,"marketStatus":"盘后交易","marketStatusCode":4,"change":0,"latestTime":"07-23 17:22:29 EDT","open":22.93,"high":22.93,"low":22.93,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.995355,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721779200000},"adr":0,"listingDate":1612414800000,"adjPreClose":22.93,"volumeRatio":0},"requestUrl":"/m/hq/s/LABP","defaultTab":"news","newsList":[{"id":"2422054864","title":"今日优惠-兼并与收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2422054864","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422054864?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:49","pubTimestamp":1711374572,"startTime":"0","endTime":"0","summary":"     路透社3月25日 - 截至格林尼治标准时间周一 1330 时，报道了以下竞购、兼并、收购和处置：    ** 艾伯维  和Landos Biopharma  将以高达2.12亿美元的价格收购药物开发商Landos Biopharma  。** Arrow Holdings提交了一份不具约束力的提案，拟以每股10.80美元的价格收购其尚未持有的租赁和酒店服务公司Target Hospitality Corp   的剩余股份。** 英格索兰  将以约23.3亿美元的价格从投资公司New Mountain Capital手中收购ILC Dover，这家空气压缩机制造商表示，这将加强其在生命科学市场的业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABP","BK4007"],"gpt_icon":0},{"id":"2422651028","title":"Landos Biopharma, Inc.盘中异动 早盘大幅上涨176.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422651028","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422651028?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:31","pubTimestamp":1711373468,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时31分，Landos Biopharma, Inc.股票出现波动，股价急速上涨176.37%。Landos Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为603.90%、46.24%、30.61%，振幅较大的相关个股有Xtl生物制药、Cara Therapeutics, Inc.、Altamira Therapeutics Ltd.，振幅分别为7.25%、7.03%、6.94%。Landos Biopharma, Inc.公司简介：Landos Biopharma Inc 是一家临床阶段的生物制药公司，专注于为自身免疫性疾病患者发现和开发口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521310887b340e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521310887b340e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LABP"],"gpt_icon":0},{"id":"2422179635","title":"BUZZ-受艾伯维收购交易影响，兰多斯生物制药公司业绩大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2422179635","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422179635?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:24","pubTimestamp":1711373062,"startTime":"0","endTime":"0","summary":"    3月25日 - ** 疗法开发商兰多斯生物制药公司  的股价盘前上涨两倍多，达到23.56美元 ** 艾伯维  将以最高2.12亿美元的价格收购该公司  ** 根据交易，ABBV将以每股20.42美元的现金收购Landos，总价约为1.375亿美元，比LABP上周五收盘价溢价160.8%。** ABBV还将向Landos股东支付每股最多11.14美元的额外里程碑付款，总额约为7500万美元。** 截至上一交易日收盘，LABP 的股价比去年同期翻了一番多","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU1267930490.SGD","LU0234572021.USD","LU0738911758.USD","IE00BSNM7G36.USD","LU1585245621.USD","LU1989771016.USD","LU0122379950.USD","LU0456855351.SGD","LU0820561818.USD","LU0912757837.SGD","LU1244550494.USD","LU0029864427.USD","LU0820561909.HKD","IE00BFTCPJ56.SGD","LU1244550221.USD","LU1496350502.SGD","BK4534","BK4550","BK4581","LU0949170772.SGD","LU0795875169.SGD","LU0128525929.USD","BUZZ","LU0170899867.USD","LU1244550577.SGD","LU1291159041.SGD","IE00B2B36J28.USD","LU0198837287.USD","LU0795875086.SGD","LU1430594728.SGD","LU0234570918.USD","BK4566","LU0158827948.USD","BK4139","LU0689472784.USD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU1496350171.SGD","ABBV","BK4585","LU1839511570.USD","LU0114720955.EUR","LU0661504455.SGD","LU0417517546.SGD","LABP","LU1732800096.USD","LU1057294990.SGD","LU1718418525.SGD","BK4588"],"gpt_icon":0},{"id":"2422514079","title":"更新版 1-艾伯维通过兰多斯交易加强免疫疾病药物管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2422514079","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422514079?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:03","pubTimestamp":1711371806,"startTime":"0","endTime":"0","summary":"艾伯维的大片药物 Rinvoq 已被批准用于治疗这种疾病，同时该公司还在寻求美国食品药品管理局批准其另一种主要药物 Skyrizi。根据这项交易，艾伯维将以每股 20.42 美元的现金收购兰多斯，总价约为 1.375 亿美元。在短暂停牌后，兰多斯的股价在收盘前飙升至 22.13 美元。两家公司表示，交易预计将在第二季度完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU1551013425.SGD","LU0708994859.HKD","LABP","LU0211328371.USD","IE00BJT1NW94.SGD","LU0158827948.USD","LU0234572021.USD","LU1267930573.SGD","IE00BSNM7G36.USD","LU0114720955.EUR","LU0211327993.USD","ABBV","LU1496350171.SGD","LU1839511570.USD","BK4534","LU0234570918.USD","LU1732800096.USD","LU1585245621.USD","LU0029864427.USD","LU0949170772.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0882574055.USD","LU0943347566.SGD","LU1551013342.USD","IE0009355771.USD","LU0128525929.USD","LU0661504455.SGD","LU1057294990.SGD","LU1989771016.USD","LU1023059063.AUD","BK4588","LU0310800379.SGD","LU0417517546.SGD","LU0795875169.SGD","IE0004445239.USD","LU0310799852.SGD","LU0738911758.USD","LU0256863811.USD","LU0912757837.SGD","BK4581","LU1093756325.SGD","LU1244550577.SGD","LU1244550221.USD","LU1732799900.SGD","LU0820561909.HKD","LU1291159041.SGD","BK4139","BK4585"],"gpt_icon":0},{"id":"2422519043","title":"艾伯维将收购兰多斯，扩大免疫相关疾病的产品线","url":"https://stock-news.laohu8.com/highlight/detail?id=2422519043","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422519043?lang=zh_cn&edition=full","pubTime":"2024-03-25 20:37","pubTimestamp":1711370251,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社3月25日 - 艾伯维  周一表示，将以不超过2.12亿美元的价格收购药物开发商兰多斯生物制药  ，这家Humira生产商的目标是扩大其治疗免疫系统相关疾病的药物产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4585","BK4007","LU0820561818.USD","LU1093756325.SGD","IE00B2B36J28.USD","LU1496350171.SGD","LU0689472784.USD","LU1267930573.SGD","BK4534","IE00BJJMRZ35.SGD","BK4566","LU0211328371.USD","LU0234570918.USD","LU0820561909.HKD","LU1496350502.SGD","BK4139","LU1267930490.SGD","ABBV","BK4550","LU0310800379.SGD","LU0943347566.SGD","LU1551013342.USD","IE0009355771.USD","LU0256863811.USD","IE00BFTCPJ56.SGD","LU0114720955.EUR","LU0882574055.USD","LU0456855351.SGD","IE00BSNM7G36.USD","LABP","LU1839511570.USD","LU0029864427.USD","LU0795875169.SGD","LU0198837287.USD","LU0310799852.SGD","LU1244550494.USD","LU1551013425.SGD","LU1718418525.SGD","BK4559","IE0002141913.USD","LU0949170772.SGD","LU0708994859.HKD","LU0170899867.USD","BK4588","LU0795875086.SGD","LU1732799900.SGD","LU0211327993.USD","LU1244550221.USD","LU1430594728.SGD"],"gpt_icon":0},{"id":"2421484058","title":"Landos Biopharma, Inc.盘中异动 股价大涨5.35%报8.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421484058","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421484058?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:04","pubTimestamp":1711119864,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日23时04分，Landos Biopharma, Inc.股票出现波动，股价急速拉升5.35%。Landos Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Effector Therapeutics Inc C/Wts 31/12/2025 、Outlook Therapeutics, Inc.涨幅较大，Outlook Therapeutics, Inc.、180 Life Sciences Corp.、安皮奥制药较为活跃，换手率分别为76.65%、34.57%、21.02%，振幅较大的相关个股有Matinas Biopharma Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts ，振幅分别为53.68%、43.92%、42.98%。Landos Biopharma, Inc.公司简介：Landos Biopharma Inc 是一家临床阶段的生物制药公司，专注于为自身免疫性疾病患者发现和开发口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322230425861e078f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322230425861e078f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LABP"],"gpt_icon":0},{"id":"2421504534","title":"Landos Biopharma, Inc.盘中异动 快速拉升5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421504534","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421504534?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:33","pubTimestamp":1711027999,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时33分，Landos Biopharma, Inc.股票出现异动，股价急速拉升5.56%。Landos Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Jasper Therapeutics Inc C/Wts 24/09/2026 、Argenx Se涨幅较大，Scisparc Ltd.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Xtl生物制药较为活跃，换手率分别为68.44%、14.22%、8.38%，振幅较大的相关个股有Psyence Biomedical Ltd.、Trevi Therapeutics, Inc.、Omniab, Inc.，振幅分别为10.17%、9.89%、9.59%。Landos Biopharma, Inc.公司简介：Landos Biopharma Inc 是一家临床阶段的生物制药公司，专注于为自身免疫性疾病患者发现和开发口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213319791c059d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213319791c059d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LABP"],"gpt_icon":0},{"id":"2421704583","title":"兰多斯生物制药公司公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2421704583","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421704583?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:32","pubTimestamp":1711027955,"startTime":"0","endTime":"0","summary":"   * Landos Biopharma Inc   报告，截至12月底的季度调整后每股亏损99美分，高于去年同期的每股收益1.30美元。两位分析师对该季度的平均预期是每股亏损 91 美分。华尔街预期为每股-92美分至-91美分。* Landos Biopharma Inc 报告的季度每股收益为亏损 99 美分。* 该公司当季亏损 612 万美元。* Landos Biopharma Inc 的股价本季度上涨了 91.0%。华尔街对兰道斯生物制药公司 12 个月目标价的中位数为 5.00 美元。本摘要根据兰道斯生物制药公司3月21日下午01:31的数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABP"],"gpt_icon":0},{"id":"2420289117","title":"Landos Biopharma, Inc.盘中异动 大幅拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420289117","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420289117?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:57","pubTimestamp":1710943025,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时57分，Landos Biopharma, Inc.股票出现异动，股价急速上涨5.04%。Landos Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.06%。其相关个股中，Moolec Science Sa C/Wts 、Ocean Biomedical Inc C/Wts 14/02/2028 、Taysha Gene Therapies, Inc.涨幅较大，Jaguar Health, Inc.、Tc Biopharm  Plc、Enveric Biosciences, Inc.较为活跃，换手率分别为51.07%、34.52%、19.42%，振幅较大的相关个股有Jaguar Health, Inc.、Taysha Gene Therapies, Inc.、Nls Pharmaceutics Ltd.，振幅分别为27.14%、25.16%、24.83%。Landos Biopharma, Inc.公司简介：Landos Biopharma Inc 是一家临床阶段的生物制药公司，专注于为自身免疫性疾病患者发现和开发口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320215706791bbf63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320215706791bbf63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LABP"],"gpt_icon":0},{"id":"2420001762","title":"Landos Biopharma, Inc.盘中异动 股价大涨5.42%报7.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420001762","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420001762?lang=zh_cn&edition=full","pubTime":"2024-03-20 03:46","pubTimestamp":1710877578,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日03时46分，Landos Biopharma, Inc.股票出现波动，股价大幅上涨5.42%。截至发稿，该股报7.00美元/股，成交量1.2223万股，换手率0.39%，振幅4.97%。Landos Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Landos Biopharma, Inc.公司简介：Landos Biopharma Inc 是一家临床阶段的生物制药公司，专注于为自身免疫性疾病患者发现和开发口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320034619791b7de1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320034619791b7de1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LABP"],"gpt_icon":0},{"id":"2420226732","title":"Landos Biopharma Inc   预计每股亏损91美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2420226732","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420226732?lang=zh_cn&edition=full","pubTime":"2024-03-19 20:48","pubTimestamp":1710852498,"startTime":"0","endTime":"0","summary":"   * Landos Biopharma Inc    预计在3月21日公布截至2023年12月31日的财报时，季度收入将没有变化(预计)。*    * LSEG 的分析师平均预计 Landos Biopharma Inc 每股亏损 91 美分。* 华尔街对 Landos Biopharma Inc 的 12 个月目标价中位数为 5.00 美元，低于其上一次收盘价 6.64 美元。3月19日 - 本摘要于北京时间 3 月 19 日 12:47 机器生成。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABP"],"gpt_icon":0},{"id":"2418357266","title":"Landos Biopharma, Inc.盘中异动 大幅拉升5.04%报6.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418357266","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2418357266?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:32","pubTimestamp":1710163938,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时32分，Landos Biopharma, Inc.股票出现波动，股价大幅拉升5.04%。Landos Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Biocardia Inc C/Wts 06/08/2024、Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc涨幅较大，Tc Biopharm  Plc、180 Life Sciences Corp.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为716.51%、152.95%、70.64%，振幅较大的相关个股有Equillium, Inc.、依生生物、Aprea Therapeutics, Inc.，振幅分别为11.99%、10.86%、10.86%。Landos Biopharma, Inc.公司简介：Landos Biopharma Inc 是一家临床阶段的生物制药公司，专注于为自身免疫性疾病患者发现和开发口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112132187919594b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112132187919594b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LABP"],"gpt_icon":0},{"id":"2418098867","title":"Landos Biopharma, Inc.盘中异动 股价大跌7.68%报6.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418098867","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2418098867?lang=zh_cn&edition=full","pubTime":"2024-03-09 01:40","pubTimestamp":1709919639,"startTime":"0","endTime":"0","summary":"北京时间2024年03月09日01时40分，Landos Biopharma, Inc.股票出现波动，股价急速下挫7.68%。截至发稿，该股报6.01美元/股，成交量6061股，换手率0.19%，振幅6.14%。Landos Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Landos Biopharma, Inc.公司简介：Landos Biopharma Inc 是一家临床阶段的生物制药公司，专注于为自身免疫性疾病患者发现和开发口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403090140407918ad0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403090140407918ad0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LABP"],"gpt_icon":0},{"id":"2417790329","title":"Landos Biopharma, Inc.盘中异动 股价大跌7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417790329","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417790329?lang=zh_cn&edition=full","pubTime":"2024-03-08 01:23","pubTimestamp":1709832210,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日01时23分，Landos Biopharma, Inc.股票出现波动，股价大幅下挫7.62%。Landos Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为2.97%。其相关个股中，Immuron Limited、Cingulate Inc C/Wts 10/12/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aptevo Therapeutics Inc.、Immuron Limited、Creative Medical Technology Holdings, Inc.较为活跃，换手率分别为620.47%、536.93%、489.20%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cero Therapeutics Holdings, Inc.、Immuron Limited，振幅分别为409.11%、258.86%、106.05%。Landos Biopharma, Inc.公司简介：Landos Biopharma Inc 是一家临床阶段的生物制药公司，专注于为自身免疫性疾病患者发现和开发口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030801233079184d57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030801233079184d57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LABP"],"gpt_icon":0},{"id":"2413241690","title":"Landos Biopharma Inc盘中异动 股价大跌6.75%报5.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413241690","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413241690?lang=zh_cn&edition=full","pubTime":"2024-02-23 01:42","pubTimestamp":1708623773,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日01时42分，Landos Biopharma Inc股票出现异动，股价快速下挫6.75%。截至发稿，该股报5.39美元/股，成交量1052股，换手率0.03%，振幅1.38%。Landos Biopharma Inc股票所在的生物技术行业中，整体涨幅为1.98%。Landos Biopharma Inc公司简介：Landos Biopharma Inc 是一家临床阶段的生物制药公司，专注于为自身免疫性疾病患者发现和开发口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402230142537a45c33c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402230142537a45c33c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LABP"],"gpt_icon":0},{"id":"2411587134","title":"Landos Biopharma Inc盘中异动 急速上涨5.04%报5.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411587134","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411587134?lang=zh_cn&edition=full","pubTime":"2024-02-15 02:16","pubTimestamp":1707934576,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日02时16分，Landos Biopharma Inc股票出现异动，股价急速拉升5.04%。截至发稿，该股报5.47美元/股，成交量5988股，换手率0.19%，振幅4.99%。Landos Biopharma Inc股票所在的生物技术行业中，整体涨幅为0.64%。Landos Biopharma Inc公司简介：Landos Biopharma Inc 是一家临床阶段的生物制药公司，专注于为自身免疫性疾病患者发现和开发口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240215021617861d5433&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240215021617861d5433&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LABP"],"gpt_icon":0},{"id":"2411637943","title":"Landos Biopharma Inc盘中异动 早盘快速下跌10.56%报4.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411637943","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411637943?lang=zh_cn&edition=full","pubTime":"2024-02-13 23:07","pubTimestamp":1707836828,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日23时07分，Landos Biopharma Inc股票出现异动，股价急速下跌10.56%。截至发稿，该股报4.83美元/股，成交量13股，换手率0.00%，振幅0.00%。Landos Biopharma Inc股票所在的生物技术行业中，整体跌幅为0.72%。Landos Biopharma Inc公司简介：Landos Biopharma Inc 是一家临床阶段的生物制药公司，专注于为自身免疫性疾病患者发现和开发口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021323070879113d3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021323070879113d3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LABP","BK4007"],"gpt_icon":0},{"id":"2408936319","title":"Landos Biopharma Inc盘中异动 股价大跌5.19%报5.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2408936319","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2408936319?lang=zh_cn&edition=full","pubTime":"2024-02-03 00:22","pubTimestamp":1706890963,"startTime":"0","endTime":"0","summary":"北京时间2024年02月03日00时22分，Landos Biopharma Inc股票出现波动，股价大幅下跌5.19%。截至发稿，该股报5.11美元/股，成交量1550股，换手率0.05%，振幅2.78%。Landos Biopharma Inc股票所在的生物技术行业中，整体跌幅为1.32%。Landos Biopharma Inc公司简介：Landos Biopharma Inc 是一家临床阶段的生物制药公司，专注于为自身免疫性疾病患者发现和开发口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240203002243861d1562&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240203002243861d1562&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LABP"],"gpt_icon":0},{"id":"2408866410","title":"Landos Biopharma Inc盘中异动 大幅下跌5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408866410","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2408866410?lang=zh_cn&edition=full","pubTime":"2024-02-02 04:54","pubTimestamp":1706820886,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日04时54分，Landos Biopharma Inc股票出现异动，股价大幅跳水5.54%。Landos Biopharma Inc股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Neurobo Pharmaceuticals Inc、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大，Gri Bio Inc、Neurobo Pharmaceuticals Inc、Revelation Biosciences Inc较为活跃，换手率分别为3066.03%、1385.36%、1187.06%，振幅较大的相关个股有Gri Bio Inc、Kiora Pharmaceuticals Inc、Neurobo Pharmaceuticals Inc，振幅分别为207.75%、69.32%、64.22%。Landos Biopharma Inc公司简介：Landos Biopharma Inc 是一家临床阶段的生物制药公司，专注于为自身免疫性疾病患者发现和开发口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020204544687e6b3fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020204544687e6b3fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LABP","BK4007"],"gpt_icon":0},{"id":"2408557156","title":"Landos Biopharma Inc盘中异动 股价大涨9.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408557156","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2408557156?lang=zh_cn&edition=full","pubTime":"2024-01-31 23:38","pubTimestamp":1706715501,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日23时38分，Landos Biopharma Inc股票出现波动，股价大幅拉升9.40%。Landos Biopharma Inc股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，2Seventy Bio Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Vaxart Inc涨幅较大，Revelation Biosciences Inc、Ensysce Biosciences Inc、Neximmune Inc较为活跃，换手率分别为701.85%、481.86%、311.01%，振幅较大的相关个股有Neximmune Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Revelation Biosciences Inc，振幅分别为66.53%、49.63%、48.43%。Landos Biopharma Inc公司简介：Landos Biopharma Inc 是一家临床阶段的生物制药公司，专注于为自身免疫性疾病患者发现和开发口服疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401312338217a402345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401312338217a402345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LABP","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.landosbiopharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.0352},{"period":"6month","weight":4.0396},{"period":"1year","weight":4.5655},{"period":"ytd","weight":5.265}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.1427},{"period":"1year","weight":0.2266},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Landos Biopharma, Inc.于2017年1月在特拉华州注册成立，是一家临床阶段的生物制药公司，致力于发现和开发针对自身免疫性疾病患者的口服治疗药物。他们的核心专长是开发针对新途径的免疫和新陈代谢治疗候选药物。 基于他们对细胞代谢途径在调节炎症反应中的作用的了解，他们旨在通过改变靶细胞的代谢过程来抑制这些炎症反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.009764},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.10816},{"month":3,"riseRate":0.25,"avgChangeRate":0.400461},{"month":4,"riseRate":0.5,"avgChangeRate":-0.056684},{"month":5,"riseRate":0.25,"avgChangeRate":-0.058276},{"month":6,"riseRate":0.75,"avgChangeRate":0.144659},{"month":7,"riseRate":0.25,"avgChangeRate":-0.002056},{"month":8,"riseRate":0.666667,"avgChangeRate":0.081967},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.034529},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.175667},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.261482},{"month":12,"riseRate":0.333333,"avgChangeRate":0.289215}],"exchange":"NASDAQ","name":"Landos Biopharma, Inc.","nameEN":"Landos Biopharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Landos Biopharma, Inc.(LABP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Landos Biopharma, Inc.(LABP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Landos Biopharma, Inc.,LABP,Landos Biopharma, Inc.股票,Landos Biopharma, Inc.股票老虎,Landos Biopharma, Inc.股票老虎国际,Landos Biopharma, Inc.行情,Landos Biopharma, Inc.股票行情,Landos Biopharma, Inc.股价,Landos Biopharma, Inc.股市,Landos Biopharma, Inc.股票价格,Landos Biopharma, Inc.股票交易,Landos Biopharma, Inc.股票购买,Landos Biopharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Landos Biopharma, Inc.(LABP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Landos Biopharma, Inc.(LABP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况